News and Announcements
MedAdvisor AGM CEO Presentation
- Published October 27, 2016 12:24PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th October 2016, ASX Announcement
FY16 Results Overview
- Total revenue of $1.76m, representing a 24% increase on FY15 on a normalised basis
– Normalised basis excludes a final license fee payment of $500,000 from FY15 revenue of $1.9 million - Revenue from pharmacy subscriptions and patient engagement programs (PEP) up 24% to $1.43 million
– Additional revenue streams expected to go live during FY17 - Gross profit of $925k, up 133% on FY15
- Gross margin from pharmacy subscriptions increased to 71%, from 43% in the prior corresponding period
- Net loss of $3.07 million due to increased costs and investments in expanding marketing and sales initiatives for further expansion in FY17
To view the full announcement, please click on the button below.